{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:57:40Z","timestamp":1649062660622},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00059-019-4805-8","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:54:31Z","timestamp":1557161671000},"page":"289-295","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ESUS (\u201eembolic stroke of undetermined source\u201c)"],"prefix":"10.1007","volume":"44","author":[{"given":"T.","family":"Stegmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.\u2011R.","family":"Sch\u00e4bitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"4805_CR1","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/hs1201.100209","volume":"32","author":"PL Kolominsky-Rabas","year":"2001","unstructured":"Kolominsky-Rabas PL, Weber M, Gefeller O et al (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a\u00a0population-based study. Stroke 32:2735\u20132740","journal-title":"Stroke"},{"key":"4805_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","volume":"14","author":"L Li","year":"2015","unstructured":"Li L, Yiin GS, Geraghty OC et al (2015) Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a\u00a0population-based study. Lancet Neurol 14:903\u2013913. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(15)00132-5","journal-title":"Lancet Neurol"},{"key":"4805_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener H\u2011C, Coutts SB et al (2014) Embolic strokes of undetermined source: the case for a\u00a0new clinical construct. Lancet Neurol 13:429\u2013438. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70310-7","journal-title":"Lancet Neurol"},{"key":"4805_CR4","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1161\/STROKEAHA.118.022986","volume":"49","author":"T Komatsu","year":"2018","unstructured":"Komatsu T, Iguchi Y, Arai A et\u00a0al (2018) Large but nonstenotic carotid artery plaque in patients with a\u00a0history of embolic stroke of undetermined source. Stroke 49:3054\u20133056. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.118.022986","journal-title":"Stroke"},{"key":"4805_CR5","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"Hart RG, Sharma M, Mundi H et\u00a0al (2018) Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N\u00a0Engl J Med 378:2191\u20132201. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1802686","journal-title":"N Engl J Med"},{"key":"4805_CR6","volume-title":"Late breaking clinical trial","author":"Diener","year":"2018","unstructured":"Diener et\u00a0al (2018) Late breaking clinical trial. World Stroke Congress Montreal."},{"key":"4805_CR7","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et\u00a0al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart\u00a0J 37:2893\u20132962. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"key":"4805_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.002864","author":"GYH Lip","year":"2017","unstructured":"Lip GYH, Hunter TD, Quiroz ME et\u00a0al (2017) Atrial fibrillation diagnosis timing, ambulatory ECG monitoring utilization, and risk of recurrent stroke. Circ Cardiovasc Qual Outcomes. \n                    https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.002864","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"4805_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857. \n                    https:\/\/doi.org\/10.7326\/0003-4819-146-12-200706190-00007","journal-title":"Ann Intern Med"},{"key":"4805_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a\u00a0meta-analysis of randomised trials. Lancet 383:955\u2013962. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"4805_CR11","doi-asserted-by":"publisher","first-page":"e0166091","DOI":"10.1371\/journal.pone.0166091","volume":"11","author":"A Arauz","year":"2016","unstructured":"Arauz A, Morelos E, Col\u00edn J et\u00a0al (2016) Comparison of functional outcome and stroke recurrence in patients with embolic stroke of undetermined source (ESUS) vs. cardioembolic stroke patients. PLoS ONE 11:e166091. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0166091","journal-title":"PLoS ONE"},{"key":"4805_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000131083","volume":"25","author":"The European Stroke Organisation","year":"2008","unstructured":"The European Stroke Organisation, Executive Committee, ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457\u2013507. \n                    https:\/\/doi.org\/10.1159\/000131083","journal-title":"Cerebrovasc Dis"},{"key":"4805_CR13","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR et\u00a0al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 45:2160\u20132236. \n                    https:\/\/doi.org\/10.1161\/STR.0000000000000024","journal-title":"Stroke"},{"key":"4805_CR14","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ, Spring M, Dorian P et\u00a0al (2014) Atrial fibrillation in patients with cryptogenic stroke. N\u00a0Engl J Med 370:2467\u20132477. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1311376","journal-title":"N Engl J Med"},{"key":"4805_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0871-1","author":"KG Haeusler","year":"2018","unstructured":"Haeusler KG, T\u00fct\u00fcnc\u00fc S, Schnabel RB (2018) Detection of atrial fibrillation in cryptogenic stroke. Curr Neurol Neurosci Rep. \n                    https:\/\/doi.org\/10.1007\/s11910-018-0871-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4805_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","volume":"16","author":"R Wachter","year":"2017","unstructured":"Wachter R, Gr\u00f6schel K, Gelbrich G et al (2017) Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF RANDOMISED): an open-label randomised controlled trial. Lancet Neurol 16:282\u2013290. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(17)30002-9","journal-title":"Lancet Neurol"},{"key":"4805_CR17","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener H\u2011C, Passman RS et al (2014) Cryptogenic stroke and underlying atrial fibrillation. N\u00a0Engl J Med 370:2478\u20132486. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1313600","journal-title":"N Engl J Med"},{"key":"4805_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ahj.2015.10.010","volume":"172","author":"KG Haeusler","year":"2016","unstructured":"Haeusler KG, Kirchhof P, Heuschmann PU et\u00a0al (2016) Impact of standardized MONitoring for detection of atrial fibrillation in ischemic stroke (MonDAFIS): Rationale and design of a\u00a0prospective randomized multicenter study. Am Heart\u00a0J 172:19\u201325. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2015.10.010","journal-title":"Am Heart J"},{"key":"4805_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007448","author":"H Makimoto","year":"2017","unstructured":"Makimoto H, Kurt M, Gliem M et\u00a0al (2017) High incidence of atrial fibrillation after embolic stroke of undetermined source in posterior cerebral artery territory. J\u00a0Am Heart Assoc. \n                    https:\/\/doi.org\/10.1161\/JAHA.117.007448","journal-title":"J Am Heart Assoc"},{"key":"4805_CR20","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1160\/TH17-02-0072","volume":"117","author":"C Israel","year":"2017","unstructured":"Israel C, Kitsiou A, Kalyani M et\u00a0al (2017) Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders. Thromb Haemost 117:1962\u20131969. \n                    https:\/\/doi.org\/10.1160\/TH17-02-0072","journal-title":"Thromb Haemost"},{"key":"4805_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1055\/s-0043-118476","volume":"45","author":"K H\u00e4usler","year":"2018","unstructured":"H\u00e4usler K, Gr\u00f6schel K, K\u00f6hrmann M et al (2018) Positionspapier zur Detektion von Vorhofflimmern nach isch\u00e4mischem Schlaganfall: Arbeitsgemeinschaft Herz und Hirn der Deutschen Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung e.\u202fV. (DGK) und der Deutschen Schlaganfall-Gesellschaft e.\u202fV. (DSG). Aktuelle Neurol 45:93\u2013106. \n                    https:\/\/doi.org\/10.1055\/s-0043-118476","journal-title":"Aktuelle Neurol"},{"key":"4805_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00392-018-1256-9","volume":"107","author":"KG Haeusler","year":"2018","unstructured":"Haeusler KG, Gr\u00f6schel K, K\u00f6hrmann M et\u00a0al (2018) Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clin Res Cardiol 107:871\u2013880. \n                    https:\/\/doi.org\/10.1007\/s00392-018-1256-9","journal-title":"Clin Res Cardiol"},{"key":"4805_CR23","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00415-013-6935-x","volume":"260","author":"R Wachter","year":"2013","unstructured":"Wachter R, Weber-Kr\u00fcger M, Seegers J et al (2013) Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J\u00a0Neurol 260:2042\u20132045. \n                    https:\/\/doi.org\/10.1007\/s00415-013-6935-x","journal-title":"J Neurol"},{"key":"4805_CR24","volume-title":"Herzrhythmusst\u00f6rungen: Diagnostik Und Therapie","author":"T Lewalter","year":"2010","unstructured":"Lewalter T, L\u00fcderitz B (2010) Herzrhythmusst\u00f6rungen: Diagnostik Und Therapie. Springer, Dordrecht"},{"key":"4805_CR25","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.jacc.2018.03.003","volume":"71","author":"JM Bumgarner","year":"2018","unstructured":"Bumgarner JM, Lambert CT, Hussein AA et\u00a0al (2018) Smartwatch algorithm for automated detection of atrial fibrillation. J\u00a0Am Coll Cardiol 71:2381\u20132388. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.03.003","journal-title":"J Am Coll Cardiol"},{"key":"4805_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ahj.2018.09.002","volume":"207","author":"MP Turakhia","year":"2019","unstructured":"Turakhia MP, Desai M, Hedlin H et al (2019) Rationale and design of a\u00a0large-scale, app-based study to identify cardiac arrhythmias using a\u00a0smartwatch: The Apple Heart Study. Am Heart\u00a0J 207:66\u201375. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2018.09.002","journal-title":"Am Heart J"},{"issue":"2","key":"4805_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR et\u00a0al (2012) Subclinical atrial fibrillation and the risk of stroke. N\u00a0Engl J Med 366(2):120\u2013129","journal-title":"N Engl J Med"},{"key":"4805_CR28","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","volume":"38","author":"IC Van Gelder","year":"2017","unstructured":"Van Gelder IC, Healey JS, Crijns HJGM et al (2017) Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart\u00a0J 38:1339\u20131344. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehx042","journal-title":"Eur Heart J"},{"key":"4805_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ahj.2017.04.008","volume":"189","author":"RD Lopes","year":"2017","unstructured":"Lopes RD, Alings M, Connolly SJ et al (2017) Rationale and design of the Apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA) trial. Am Heart\u00a0J 189:137\u2013145. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2017.04.008","journal-title":"Am Heart J"},{"key":"4805_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ahj.2017.04.015","volume":"190","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof P, Blank BF, Calvert M et al (2017) Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH\u2013AFNET 6) trial. Am Heart\u00a0J 190:12\u201318. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2017.04.015","journal-title":"Am Heart J"},{"key":"4805_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","volume":"14","author":"B Freedman","year":"2017","unstructured":"Freedman B, Boriani G, Glotzer TV et al (2017) Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nat Rev Cardiol 14:701. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2017.94","journal-title":"Nat Rev Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4805-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-019-4805-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4805-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T23:26:21Z","timestamp":1588634781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-019-4805-8"}},"subtitle":["Wie viel Monitoring ist n\u00f6tig?"],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4805"],"URL":"https:\/\/doi.org\/10.1007\/s00059-019-4805-8","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"6 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Wachter hat Honorar f\u00fcr Vortr\u00e4ge und\/oder Reisekostenerstattung und\/oder Advisory Boards von folgenden Firmen erhalten: Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, Pfizer. Seine Forschung wird unterst\u00fctzt vom Bundesministerium f\u00fcr Bildung und Forschung (BMBF), von der Europ\u00e4ischen Union (EU) und von Boehringer Ingelheim. W.-R.\u00a0Sch\u00e4bitz hat Honorar f\u00fcr Vortr\u00e4ge und\/oder Reisekostenerstattung und\/oder Advisory Boards von folgenden Firmen erhalten: Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Medtronic. T.\u00a0Stegmann gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}